Drug comparisons
Acetohexamide vs Vildagliptin
Compare Acetohexamide (sulfonylurea) vs Vildagliptin (DPP-4 inhibitor) for type 2 diabetes: efficacy, hypoglycemia risk, weight effects, and suitability.
No comparison dimensions are available for this page.
Clinical context
This comparison occurs when evaluating older first-generation sulfonylureas against modern DPP-4 inhibitors for type 2 diabetes patients concerned about hypoglycemia or weight gain.
Bottom line
Vildagliptin typically offers a safer profile than Acetohexamide for most type 2 diabetes patients.
All medication comparisons